Temsirolimus

You have access
The Combination of Trametinib, a MEK Inhibitor, and Temsirolimus, an mTOR Inhibitor, Radiosensitizes Lung Cancer Cells
SEO YUN KIM, EUN-HUI JEONG, TAE-GUL LEE, HYE-RYOUN KIM and CHEOL HYEON KIM

Anticancer Research June 2021, 41 (6) 2885-2894; DOI: https://doi.org/10.21873/anticanres.15070
You have access
Low-dose Docetaxel Enhanced the Anticancer Effect of Temsirolimus by Overcoming Autophagy in Prostate Cancer Cells
SO INAMURA, HIDEAKI ITO, MINEKATSU TAGA, KATSUKI TSUCHIYAMA, HITOMI HOSHINO, MOTOHIRO KOBAYASHI and OSAMU YOKOYAMA

Anticancer Research October 2019, 39 (10) 5417-5425; DOI: https://doi.org/10.21873/anticanres.13735
You have access
Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature
KRISTEN D. STARBUCK, RICHARD D. DRAKE, G. THOMAS BUDD and PETER G. ROSE

Anticancer Research November 2016, 36 (11) 6161-6164;
You have access
Risk of Metabolic Complications in Patients with Solid Tumors Treated with mTOR inhibitors: Meta-analysis
SUNGYUB LEW and RONALD S. CHAMBERLAIN

Anticancer Research April 2016, 36 (4) 1711-1718;
You have access
A Retrospective Study of Patients with Malignant PEComa Receiving Treatment with Sirolimus or Temsirolimus: The Royal Marsden Hospital Experience
CHARLOTTE BENSON, JOANNA VITFELL-RASMUSSEN, MARCO MARUZZO, CYRIL FISHER, NINA TUNARIU, SCOTT MITCHELL, OMAR AL-MUDERIS, KHIN THWAY, JAMES LARKIN and IAN JUDSON

Anticancer Research July 2014, 34 (7) 3663-3668;
You have access
Pediatric Patients with Refractory Central Nervous System Tumors: Experiences of a Clinical Trial Combining Bevacizumab and Temsirolimus
SARINA A. PIHA-PAUL, SANG JOON SHIN, TRIBHAWAN VATS, NANDITA GUHA-THAKURTA, JOANN AARON, MICHAEL RYTTING, EUGENIE KLEINERMAN and RAZELLE KURZROCK

Anticancer Research April 2014, 34 (4) 1939-1945;
You have access
Phase II Study of Bevacizumab and Temsirolimus Combination Therapy for Recurrent Glioblastoma Multiforme
ULRIK LASSEN, MORTEN SORENSEN, TINE BERNHARDTSEN GAZIEL, BENEDIKTE HASSELBALCH and HANS SKOVGAARD POULSEN

Anticancer Research April 2013, 33 (4) 1657-1660;
You have access
The Mammalian Target of Rapamycin Inhibitors in Breast Cancer: Current Evidence and Future Directions
PAOLA MALAGUTI, SABRINA VARI, FRANCESCO COGNETTI and ALESSANDRA FABI

Anticancer Research January 2013, 33 (1) 21-28;

Main menu

User menu

Search

Temsirolimus